Nasus Pharma is trading at $3.36, up 5.4% today as broader U.S. equities rally sharply despite a lack of fresh company-specific catalysts.
- The upward move appears driven by prevailing risk-on market sentiment and thin liquidity rather than internal corporate developments.
- With major indices climbing nearly 2%, the stock's performance is currently aligned with a broader macro-driven rally.